A detailed history of Valley National Advisers Inc transactions in Organon & Co. stock. As of the latest transaction made, Valley National Advisers Inc holds 128 shares of OGN stock, worth $1,959. This represents 0.0% of its overall portfolio holdings.

Number of Shares
128
Previous 506 74.7%
Holding current value
$1,959
Previous $10,000 80.0%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024

SELL
$18.65 - $23.03 $7,049 - $8,705
-378 Reduced 74.7%
128 $2,000
Q1 2024

Apr 19, 2024

SELL
$13.78 - $18.8 $1,474 - $2,011
-107 Reduced 17.46%
506 $9,000
Q4 2023

Jan 25, 2024

BUY
$10.95 - $17.32 $459 - $727
42 Added 7.36%
613 $8,000
Q3 2023

Nov 13, 2023

BUY
$16.59 - $23.77 $497 - $713
30 Added 5.55%
571 $10,000
Q2 2023

Jul 31, 2023

SELL
$19.27 - $24.63 $2,370 - $3,029
-123 Reduced 18.52%
541 $12,000
Q1 2023

Apr 26, 2023

BUY
$21.42 - $32.08 $3,919 - $5,870
183 Added 38.05%
664 $16,000
Q4 2022

Jan 12, 2023

SELL
$23.31 - $28.61 $2,307 - $2,832
-99 Reduced 17.07%
481 $14,000
Q3 2022

Nov 08, 2022

SELL
$23.4 - $34.25 $2,597 - $3,801
-111 Reduced 16.06%
580 $14,000
Q2 2022

Jul 15, 2022

SELL
$31.66 - $38.9 $2,247 - $2,761
-71 Reduced 9.32%
691 $23,000
Q1 2022

May 06, 2022

SELL
$30.45 - $39.36 $6,546 - $8,462
-215 Reduced 22.01%
762 $27,000
Q4 2021

Feb 11, 2022

BUY
$28.67 - $37.13 $28 - $37
1 Added 0.1%
977 $30,000
Q3 2021

Nov 10, 2021

SELL
$28.63 - $35.64 $11,910 - $14,826
-416 Reduced 29.89%
976 $32,000
Q2 2021

Aug 02, 2021

BUY
$28.45 - $38.0 $39,602 - $52,896
1,392 New
1,392 $42,000

Others Institutions Holding OGN

About Organon & Co.


  • Ticker OGN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 254,330,000
  • Market Cap $3.89B
  • Description
  • Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...
More about OGN
Track This Portfolio

Track Valley National Advisers Inc Portfolio

Follow Valley National Advisers Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Valley National Advisers Inc, based on Form 13F filings with the SEC.

News

Stay updated on Valley National Advisers Inc with notifications on news.